Carotinoids for a growing market
Port Salvo – Biotrend S.A., developers of high-value compounds based in Lisbon, has closed a second investment round with the public venture capital outfit PME Investimientos, ending with a total investment exceeding 1 million euros.
With this investment, Biotrend wants to move from the research stages to an industrialised enterprise. Its first step is in challenging the flourishing world market of beta carotenes. As these are still often manufactured from petroleum-based raw materials, Biotrend is focusing on a market that prefers natural products. The company uses a bioprocessed beta-carotene variant based on a newly-isolated alpha-Proteobacterium. The successful distribution of beta carotene will serve to ameliorate the production processes of other carotenoids such as lycopene and cantaxanthin, used as additives in the foods and cosmetics industry.